Health Committee: 5-year survival rate of malignant tumors has been raised to 40.5%

On June 8, the National Health And Wellness Board held a special press conference to introduce China's upgrading of medical technical capabilities and medical quality management level.
According to the Lancet magazine, the latest global healthcare quality and accessibility rankings have been released, and our HAQ index has risen from 60th in the world in 2015 to 48th in 2016, and we have jumped 12 places in a year, making significant progress again, making it one of the most advanced countries in the middle SDI.
, the five-year survival rate of malignant tumors has increased from 30.9% 10 years ago to 40.5%.The increase in
was significant: uterine cancer, from 55.1% to 72.8%, thyroid cancer, from 67.5% to 84.3%, cervical cancer, from 45.4% to 59.8%, bone tumor, from 17.1% to 26.5%, and esophageal cancer from 20.5% 9% rose to 30.3%, the five-year survival rate of some tumors has been higher than the United States and other developed countries, such as esophageal cancer, the United States in the same period only 20%, according to the number of cases, leukemia, central nervous system tumors, lymphoma accounted for 66.2% of all childhood tumors, China's overall five-year survival rate of childhood malignant tumors is about 72%, slightly lower than the United States 78%. Among them, 70.5 percent of leukemia and 69.9 percent of central nervous tumors, close to the United States levels of 74 percent and 72 percent.
.